BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 22329758)

  • 1. Human cytomegalovirus persistence.
    Goodrum F; Caviness K; Zagallo P
    Cell Microbiol; 2012 May; 14(5):644-55. PubMed ID: 22329758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
    Noriega VM; Haye KK; Kraus TA; Kowalsky SR; Ge Y; Moran TM; Tortorella D
    J Virol; 2014 Aug; 88(16):9391-405. PubMed ID: 24920803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency.
    Caviness K; Bughio F; Crawford LB; Streblow DN; Nelson JA; Caposio P; Goodrum F
    mBio; 2016 Mar; 7(2):e01986. PubMed ID: 26933055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?
    Wills MR; Poole E; Lau B; Krishna B; Sinclair JH
    Cell Mol Immunol; 2015 Mar; 12(2):128-38. PubMed ID: 25132454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34
    Crawford LB; Hancock MH; Struthers HM; Streblow DN; Yurochko AD; Caposio P; Goodrum FD; Nelson JA
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation.
    Collins-McMillen D; Buehler J; Peppenelli M; Goodrum F
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30127257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.
    Gredmark-Russ S; Söderberg-Nauclér C
    Virulence; 2012 Nov; 3(7):621-34. PubMed ID: 23076329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency.
    Cheung AK; Gottlieb DJ; Plachter B; Pepperl-Klindworth S; Avdic S; Cunningham AL; Abendroth A; Slobedman B
    Blood; 2009 Nov; 114(19):4128-37. PubMed ID: 19706889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Cytomegalovirus Latency: Approaching the Gordian Knot.
    Goodrum F
    Annu Rev Virol; 2016 Sep; 3(1):333-357. PubMed ID: 27501258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus manipulation of latently infected cells.
    Sinclair JH; Reeves MB
    Viruses; 2013 Nov; 5(11):2803-24. PubMed ID: 24284875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse immune evasion strategies by human cytomegalovirus.
    Noriega V; Redmann V; Gardner T; Tortorella D
    Immunol Res; 2012 Dec; 54(1-3):140-51. PubMed ID: 22454101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of human cytomegalovirus persistence and latency.
    Jarvis MA; Nelson JA
    Front Biosci; 2002 Jun; 7():d1575-82. PubMed ID: 12045013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Battle between Host Immune Cellular Responses and HCMV Immune Evasion.
    Manandhar T; Hò GT; Pump WC; Blasczyk R; Bade-Doeding C
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleepless latency of human cytomegalovirus.
    Poole E; Sinclair J
    Med Microbiol Immunol; 2015 Jun; 204(3):421-9. PubMed ID: 25772624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Cytomegalovirus miR-US33as-5p Targets IFNAR1 to Achieve Immune Evasion During Both Lytic and Latent Infection.
    Zhang Q; Song X; Ma P; Lv L; Zhang Y; Deng J; Zhang Y
    Front Immunol; 2021; 12():628364. PubMed ID: 33746965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular reservoirs of latent cytomegaloviruses.
    Reddehase MJ; Lemmermann NAW
    Med Microbiol Immunol; 2019 Aug; 208(3-4):391-403. PubMed ID: 31011793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latency and reactivation of human cytomegalovirus.
    Sissons JG; Bain M; Wills MR
    J Infect; 2002 Feb; 44(2):73-7. PubMed ID: 12076064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing.
    Shnayder M; Nachshon A; Krishna B; Poole E; Boshkov A; Binyamin A; Maza I; Sinclair J; Schwartz M; Stern-Ginossar N
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytomegalovirus latent infection and associated viral gene expression.
    Slobedman B; Cao JZ; Avdic S; Webster B; McAllery S; Cheung AK; Tan JC; Abendroth A
    Future Microbiol; 2010 Jun; 5(6):883-900. PubMed ID: 20521934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 superinfection in CD14
    Payen SH; Adhikari K; Petereit J; Uppal T; Rossetto CC; Verma SC
    Virus Res; 2024 Jul; 345():199375. PubMed ID: 38642618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.